Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction.
Garcia
C D
CD
Complexo Hospitalar, Santa Casa, Porto Alegre, Brazil. cdgarcia@terra.com.br
Schneider
L
L
Barros
V R
VR
Guimarães
P C
PC
Garcia
V D
VD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D002648:Child; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology / Q000706:statistics & numerical data*; D008297:Male; D011183:Postoperative Complications / Q000145:classification; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D000077552:Basiliximab; D003404:Creatinine; D016559:Tacrolimus